Sector portfolio · Private equity · Netherlands
Gilde Healthcare's Biotech portfolio
Gilde Healthcare has backed 11 Biotech startups in rounds we track, $1.3B between them, shown by the stage each has reached. The best-funded is Symphogen.
Funding by segment
- Stage not reported$279M4
- Series C and later$477M4
- Growth$529M3
Where they are based
- United States5$369M
- United Kingdom2$112M
- Netherlands1$189M
- Spain1$122M
- Denmark1$360M
- France1$134M
United States
United Kingdom
Netherlands
Spain
Denmark
FranceFounded
1 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M4
- $50M to $250M6
- $250M to $1B1
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
10 of 11 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States5
- United Kingdom2
- Netherlands1
- Spain1
- Denmark1
- France1
Startups by country, 6 countries in all.
Segment by segment
Stage not reported
4 startups · $279M raised
Ablative SolutionsAblative Solutions is a clinical-stage medical device company founded in 2011, based in Wakefield, Massachusetts.United States$130M
Chroma TherapeuticsChroma Therapeutics is a biotechnology company located in Oxford/Abingdon, UK.United Kingdom$78M
Vesper MedicalVesper Medical is committed to developing safe, efficacious and easy-to-use products for patients.United States$37M
EvotecEuprotec was acquired by Evotec in 2014.United Kingdom$34M
Series C and later
4 startups · $477M raised
AM PharmaAM-Pharma is a Dutch clinical-stage biopharmaceutical company founded in 2001 and based in Utrecht, Netherlands.Netherlands$189M
MoximedMoximed Inc.United States$146M
SANIFITSANIFIT is a biotechnology company that develops treatments for patients with calcification disorders.Spain$122M- AAxonicsUnited States$21M
Growth
3 startups · $529M raised
SymphogenSymphogen is a biotechnology company that produces recombinant polyclonal antibody drugs for disease treatment and prevention.Denmark$360M
Innate PharmaInnate Pharma S.A.France$134M
AgendiaAgendia is a molecular diagnostics company focused on precision oncology, specifically for early-stage breast cancer.United States$35M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Gilde Healthcare as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Gilde Healthcare?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.